Local drug delivery to the bone by drug-releasing implants: Perspectives of nano-engineered titania nanotube arrays

Therapeutic Delivery

Volumn 3, Issue 7, 2012, Pages 857-873

  Gulati, Karan ^a   Aw, Moom Sinn ^a   Findlay, David ^a   Losic, Dusan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; GENTAMICIN; INDOMETACIN; MULTI WALLED NANOTUBE; POLYGLACTIN; TITANIUM DIOXIDE;

BACTERIAL INFECTION; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BONE DISEASE; BONE PROSTHESIS; BONE REGENERATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOENGINEERING; NANOFABRICATION; OSTEOMYELITIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW;

EID: 84864632246     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.66     Document Type: Review

References (115)

1. Nather A. Bone Grafts and Bone Substitutes: Basic Science and Clinical Applications. World Scientific Hackensack, NJ, USA (2005).
2. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: A review in bone biomimetics and drug delivery strategies. Biotechnol. Prog. 25(6), 1539-1560 (2009).
3. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 289(5484), 1508-1514 (2000).
4. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat. Rev. Cancer. 2, 584-593 (2002).
5. Berenson JR, Rajdev L, Broder M. Treatment strategies for skeletal complications of cancer. Cancer Biol. Ther. 5(9), 1074-1077 (2006).
6. Christenson EM, Anseth KS, Van Den Beucken LJJP et al. Nanobiomaterial applications in orthopedics. J. Orthop. Res. 25(1), 11-22 (2007).
7. Fahim NF, Morks MF, Sekino T. Electrochemical synthesis of silica-doped high aspect-ratio titania nanotubes as nanobioceramics for implant applications. Electrochim. Acta 54(12), 3255-3269 (2009).
8. Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv. Drug Deliv. Rev. 55(3), 315-328 (2003).
9. Jain AK, Panchagnula R. Skeletal drug delivery systems. Int. J. Pharm. 206(1-2), 1-12 (2000).
10. Drews J. Drug discovery: A historical perspective. Science 287(5460), 1960-1964 (2000).
11. Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr. Drug Targets 5(5), 449-455 (2004).
12. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip-replacement. J. Bone. Joint. Surg. Br. 63(3), 342-353 (1981).
13. Soundrapandian C, Sa B, Datta S. Organic-inorganic composites for bone drug delivery. AAPS PharmSciTech 10(4), 1158-1171 (2009).
14. Simchi A, Tamjid E, Pishbin F, Boccaccini AR. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomedicine 7(1), 22-39 (2011).
15. Zhao L, Chu PK, Zhang Y, Wu Z. Antibacterial coatings on titanium implants. J. Biomed. Mater. Res. B Appl. Biomater. 91B(1), 470-480 (2009).
16. Tran PA, Sarin L, Hurt RH, Webster TJ. Opportunities for nanotechnology - enabled bioactive bone implants. J. Mater. Chem. 19(18), 2653-2659 (2009).
17. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J. Control. Release 130(3), 202-215 (2008).
18. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27(11), 2450-2467 (2006).
19. Lewis G. Alternative acrylic bone cement formulations for cemented arthroplasties: present status, key issues, and future prospects. J. Biomed. Mater. Res. B Appl. Biomater. 84B(2), 301-319 (2008).
20. Hoppe A, Gueldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 32(11), 2757-2774 (2011).
21. Wu C, Chang J, Xiao Y. Mesoporous bioactive glasses as drug delivery and bone tissue regeneration platforms. Therapeutic Delivery 2(9), 1189-1198 (2011).
22. Arcos D, Vallet-Regi M. Sol-gel silica-based biomaterials and bone tissue regeneration. Acta Biomater. 6(8), 2874-2888 (2010).
23. Cerruti M, Sahai N. Silicate biomaterials for orthopedic and dental implants. Rev. Mineral Geochem. 64, 283-313 (2006).
24. Arcos D, Lopez-Noriega A, Ruiz-Hernandez E, Terasaki O, Vallet-Regi M. Ordered mesoporous microspheres for bone grafting and drug delivery. Chem. Mater. 21(6), 1000-1009 (2009).
25. Ling Z, Yan Z, Bo J, Hongsong F, Xingdong Z. Characterization of an insoluble collagen sponge and the potential for tissue engineering scaffold. Mater. Sci. Forum 610-613, (2009).
26. Baro M, Sanchez E, Delgado A, Perera A, Evora C. In vitro-in vivo characterization of gentamicin bone implants. J. Control. Release 83(3), 353-364 (2002).
27. Torrado S, Frutos P, Frutos G. Gentamicin bone cements: Characterisation and release (in vitro and in vivo assays). Int. J. Pharm. 217(1-2), 57-69 (2001).
28. Timko BP, Whitehead K, Gao W et al. Advances in drug delivery. In: Annual Review of Materials Research, Volume 41. Clarke DRFP (Ed.). Annual Reviews, Palo Alto, CA, USA, 1-20 (2011).
29. Streicher RM, Scbmidt M, Fiorito S. Nanosurfaces and nanostructures for artificial orthopedic implants. Nanomedicine 2(6), 861-874 (2007).
30. Chen L, Henein G, Luciani V. Nanofabrication techniques for controlled drug-release devices. Nanomedicine 6(1), 1-6 (2011).
31. Liu H, Webster TJ. Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials 28(2), 354-369 (2007).
32. Gultepe E, Nagesha D, Sridhar S, Amiji M. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv. Drug Deliv. Rev. 62(3), 305-315 (2010).
33. Razzacki SZ, Thwar PK, Yang M, Ugaz VM, Burns MA. Integrated microsystems for controlled drug delivery. Adv. Drug Deliv. Rev. 56(2), 185-198 (2004).
34. Losic D, Simovic S. Self-ordered nanopore and nanotube platforms for drug delivery applications. Expert. Opin. Drug. Deliv. 6(12), 1363-1381 (2009).
35. Matsuda T. Device-directed therapeutic drug delivery systems. J. Control. Release 78(1-3), 125-131 (2002).
36. Roy P, Berger S, Schmuki P. TiO(2) nanotubes: Synthesis and applications. Angew. Chem. Int. Ed. Engl. 50(13), 2904-2939 (2011).
37. Ghicov A, Schmuki P. Self-ordering electrochemistry: A review on growth and functionality of TiO(2) nanotubes and other self-aligned MO(x) structures. Chem. Commun. (20), 2791-2808 (2009).
38. Grimes CA. Synthesis and application of highly ordered arrays of TiO2 nanotubes. J. Mater. Chem. 17(15), 1451-1457 (2007).
39. Macak JM, Tsuchiya H, Ghicov A et al. TiO(2) nanotubes: Self-organized electrochemical formation, properties and applications. Curr. Opin. Solid. State. Mater. Sci. 11(1-2), 3-18 (2007).
40. Rani S, Roy SC, Paulose M et al. Synthesis and applications of electrochemically self-assembled titania nanotube arrays. Phys. Chem. Chem. Phys. 12(12), 2780-2800 (2010).
41. Mor GK, Varghese OK, Paulose M, Shankar K, Grimes CA. A review on highly ordered, vertically oriented TiO2 nanotube arrays: fabrication, material properties, and solar energy applications. Sol. Energ. Mat. Sol. C 90(14), 2011-2075 (2006).
42. Zwilling V, Darque-Ceretti E, Boutry- Forveille A, David D, Perrin MY, Aucouturier M. Structure and physicochemistry of anodic oxide films on titanium and TA6V alloy. Surf. Interface Anal. 27, 629-637 (1999).
43. Macak JM, Sirotna K, Schmuki P. Self-organized porous titanium oxide prepared in Na2SO4/NaF electrolytes. Electrochim. Acta 50, 3679-3684 (2005).
44. Macak JM, Tsuchiya H, Schmuki P. High-aspect-ratio TiO2 nanotubes by anodization of titanium. Angew. Chem. Int. Ed. 44, 2100-2102 (2005).
45. Cai QY, Paulose M, Varghese OK, Grimes CA. The effect of electrolyte composition on the fabrication of self-organized titanium oxide nanotube arrays by anodic oxidation. J. Mater. Res. 20, 230-236 (2005).
46. Prakasam HE, Shankar K, Paulose M, Varghese OK, Grimes CA. A new benchmark for TiO2 nanotube array growth by anodization. J. Phys. Chem. C 111(20), 7235-7241 (2007).
47. Paulose M, Peng L, Popat KC et al. Fabrication of mechanically robust, large area, polycrystalline nanotubular/porous TiO2 membranes. J. Membr. Sci. 319(1-2), 199-205 (2008).
48. Macak JM, Albu S, Kim DH, Paramasivam I, Aldabergerova S, Schmuki P. Multilayer TiO2-nanotube formation by two-step anodization. Electrochem. Solid State 10(7), K28-K31 (2007).
49. Macak JM, Schmuki P. Anodic growth of self-organized anodic TiO2 nanotubes in viscous electrolytes. Electrochim. Acta 52(3), 1258-1264 (2006).
50. Kant K, Losic D. A simple approach for synthesis of TiO(2) nanotubes with through-hole morphology. Phys. Status Solidi RRL 3(5), 139-141 (2009).
51. Kant K, Losic D. Self-ordering electrochemical synthesis of TiO2 nanotube arrays: Controlling the nanotube geometry and the growth rate. Int. J. Nanosci. 10(1-2), 55 (2011).
52. Allam NK, Grimes CA. Formation of vertically oriented TiO2 nanotube arrays using a fluoride free HCl aqueous electrolyte. J. Phys. Chem. C 111(35), 13028-13032 (2007).
53. Albu SR, Kim D, Schmuki P. Growth of aligned TiO2 bamboo-type nanotubes and highly ordered nanolace. Angew. Chem. Int. Ed. Engl. 47(10), 1916-1919 (2008).
54. Bauer S, Kleber S, Schmuki P. TiO2 nanotubes: Tailoring the geometry in H3PO4/ HF electrolytes. Electrochem. Commun. 8(8), 1321-1325 (2006).
55. Vasilev K, Poh Z, Kant K, Chan J, Michelmore A, Losic D. Tailoring the surface functionalities of titania nanotube arrays. Biomaterials 31(3), 532-540 (2010).
56. Jani AMM, Kempson IM, Losic D, Voelcker NH. Dressing in layers: layering surface functionalities in nanoporous aluminum oxide membranes. Angew. Chem. Int. Ed. Engl. 49(43), 7933-7937 (2010).
57. Losic D, Cole MA, Dollmann B, Vasilev K, Griesser HJ. Surface modification of nanoporous alumina membranes by plasma polymerization. Nanotechnology 19(24), 245704 (2008).
58. Matsuno H, Yokoyama A, Watari F, Uo M, Kawasaki T. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials 22(11), 1253-1262 (2001).
59. De Andrade MC, Sader MS, Filgueiras MRT, Ogasawara T. Microstructure of ceramic coating on titanium surface as a result of hydrothermal treatment. J. Mater. Sci. Mater. Med. 11(11), 751-755 (2000).
60. Yang BC, Uchida M, Kim HM, Zhang XD, Kokubo T. Preparation of bioactive titanium metal via anodic oxidation treatment. Biomaterials 25(6), 1003-1010 (2004).
61. Park J, Bauer S, Von Der Mark K, Schmuki P. Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett. 7(6), 1686-1691 (2007).
62. Park J, Bauer S, Schlegel KA, Neukam FW, Von Der Mark K, Schmuki P. TiO(2) nanotube surfaces: 15 nm - an optimal length scale of surface topography for cell adhesion and differentiation. Small 5(6), 666-671 (2009).
63. Oh S, Brammer KS, Li YSJ et al. Stem cell fate dictated solely by altered nanotube dimension. Proc. Natl Acad. Sci. USA 106(7), 2130-2135 (2009).
64. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 28(32), 4880-4888 (2007).
65. Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 28(21), 3188-3197 (2007).
66. Xiao X, Yang L, Guo M, Pan C, Cai Q, Yao S. Biocompatibility and in vitro antineoplastic drug-loaded trial of titania nanotubes prepared by anodic oxidation of a pure titanium. Sci. China B 52(12), 2161-2165 (2009).
67. Burns K, Yao C, Webster TJ. Increased chondrocyte adhesion on nanotubular anodized titanium. J. Biomed. Mater. Res. A 88A(3), 561-568 (2009).
68. Ma Q, Li M, Hu Z, Chen Q, Hu W. Enhancement of the bioactivity of titanium oxide nanotubes by precalcification. Mater. Lett. 62(17-18), 3035-3038 (2008).
69. von Wilmowsky C, Bauer S, Lutz Ret al. In vivo evaluation of anodic TiO(2) nanotubes: An experimental study in the pig. J. Biomed. Mater. Res. B Appl. Biomater. 89B(1), 165-171 (2009).
70. Smith BS, Yoriya S, Grissom L, Grimes CA, Popat KC. Hemocompatibility of titania nanotube arrays. J. Biomed. Mater. Res. A 95A(2), 350-360 (2010).
71. Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32(28), 6692-6709 (2011).
72. Ainslie KM, Tao SL, Popat KC et al. In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone. J. Biomed. Mater. Res. A 91A(3), 647-655 (2009).
73. Aninwene GE, Yao C, Webster TJ. Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int. J. Nanomed. 3(2), 257-264 (2008).
74. Hunter DJ, Lo GH. The management of osteoarthritis: An overview and call to appropriate conservative treatment. Med. Clin. North Am. 93(1), 127-143 (2009).
75. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127(3), 514-525 (2007).
76. Gulati K, Ramakrishnan S, Aw MS, Atkins GJ, Findlay DM, Losic D. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomater. 8(1), 449-456 (2012).
77. Losic D, Velleman L, Kant K et al. Self-ordering electrochemistry: A simple approach for engineering nanopore and nanotube arrays for emerging applications. Aust. J. Chem. 64(3), 294-301 (2011).
78. Simovic S, Losic D, Vasilev K. Controlled drug release from porous materials by plasma polymer deposition. Chem. Commun. 46(8), 1317-1319 (2010).
79. Simovic S, Losic D, Vasilev K. Controlled release from porous platforms. Pharm. Technol. 35(8), 68-71 (2011).
80. Aw MS, Simovic S, Addai-Mensah J, Losic D. Polymeric micelles in porous and nanotubular implants as a new system for extended delivery of poorly soluble drugs. J. Mater. Chem. 21(20), 7082-7089 (2011).
81. Aw MS, Gulati K, Losic D. Controlling drug release from titania nanotube arrays using polymer nanocarriers and biopolymer coating. J. Biomater. Nanobiotechnol. 2(5), 477-484 (2011).
82. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: Active release strategies. Chem. Soc. Rev. 35(9), 780-789 (2006).
83. Kazemzadeh-Narbat M, Kindrachuk J, Duan K, Jenssen H, Hancock REW, Wang R. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31(36), 9519-9526 (2010).
84. Yao C, Webster TJ. Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method. J. Biomed. Mater. Res. B Appl. Biomater. 91B(2), 587-595 (2009).
85. Gulati K, Aw MS, Losic D. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. Nanoscale Res. Lett. 6, 571 (2011).
86. Zhao L, Wang H, Huo K et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 32(24), 5706-5716 (2011).
87. Ma M, Kazemzadeh-Narbat M, Hui Y et al. Local delivery of antimicrobial peptides using self-organized TiO(2) nanotube arrays for peri-implant infections. J. Biomed. Mater. Res. A 100A(2), 278-285 (2012).
88. Ercan B, Taylor E, Alpaslan E, Webster TJ. Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology 22(29), 295102 (2011).
89. Rungsiyakull C, Li Q, Sun G, Li W, Swain MV. Surface morphology optimization for osseointegration of coated implants. Biomaterials 31(27), 7196-7204 (2010).
90. Swami N, Cui ZW, Nair LS. Titania nanotubes: Novel nanostructures for improved osseointegration. J. Heat Trans. 133(3), 034002 (2011).
91. Sporer SM, Paprosky WG. Biologic fixation and bone ingrowth. Orthop. Clin. North Am. 36(1), 105-111 (2005).
92. Kunze J, Mueller L, Macak JM, Greil P, Schmuki P, Mueller FA. Time-dependent growth of biomimetic apatite on anodic TiO2 nanotubes. Electrochim. Acta 53(23), 6995-7003 (2008).
93. Neupane MP, Park IS, Bae TS et al. Titania nanotubes supported gelatin stabilized gold nanoparticles for medical implants. J. Mater. Chem. 21(32), 12078-12082 (2011).
94. Peng L, Mendelsohn AD, Latempa TJ, Yoriya S, Grimes CA, Desai TA. Long-term small molecule and protein elution from TiO(2) nanotubes. Nano Lett. 9(5), 1932-1936 (2009).
95. Popat KC, Eltgroth M, La Tempa TJ, Grimes CA, Desai TA. Titania nanotubes: A novel platform for drug-eluting coatings for medical implants? Small 3(11), 1878-1881 (2007).
96. Song Y-Y, Schmidt-Stein F, Bauer S, Schmuki P. Amphiphilic TiO(2) nanotube arrays: An actively controllable drug delivery system. J. Am. Chem. Soc. 131(12), 4230-4232 (2009).
97. Vasilev K, Simovic S, Losic D et al. Platforms for controlled release of antibacterial agents facilitated by plasma polymerization. Conf. Proc. IEEE Eng. Med. Biol. Soc. 811-814 (2010).
98. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24(1), 1-16 (2007).
99. Talelli M, Hennink WE. Thermosensitive polymeric micelles for targeted drug delivery. Nanomedicine 6(7), 1245-1255 (2011).
100. Aw MS, Addai-Mensah J, Losic D. A multi-drug delivery system with sequential release using titania nanotube arrays. Chem. Commun. (Camb.) 48(27), 3348-3350 (2012).
101. Aw MS, Addai-Mensah J, Losic D. Polymer micelles for delayed release of therapeutics from drug-eluting surfaces with nanotubular structures. Macromol. Biosci. doi:10.1002/ mabi.201200012 (2012) (In press).
102. Tong W, Zhu Y, Wang Z, Gao C, Moehwald H. Micelles-encapsulated microcapsules for sequential loading of hydrophobic and water-soluble drugs. Macromol. Rapid Commun. 31(11), 1015-1019 (2010).
103. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 126(3), 187-204 (2008).
104. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. Engl. 46(40), 7548-7558 (2007).
105. Shrestha NK, Macak JM, Schmidt-Stein F et al. Magnetically guided titania nanotubes for site-selective photocatalysis and drug release. Angew. Chem. Int. Ed. Engl. 48(5), 969-972 (2009).
106. Aw MS, Addai-Mensah J, Losic D. Magnetic-responsive delivery of drug-carriers using titania nanotube arrays. J. Mater. Chem. 22, 6561-6563 (2012).
107. Losic D, Yu Y, Aw MS, Simovic S, Tierry B, Addai-Mensah J. Magnetic drug delivery microcarriers with biologically derived 3-d morphologies prepared by self-assembly of iron oxide nanoparticles on diatom silica. Chem. Commun. 46, 6323-6325 (2010).
108. Hori A, Kami M, Kim SW et al. Urgent need for a validated tumor response evaluation system for use in immunotherapy. Bone Marrow Transplant. 33(2), 255-256 (2004).
109. Yang L, Webster TJ. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin. Drug Deliv. 6(8), 851-864 (2009
110. Sirivisoot S, Pareta RA, Webster TJ. A conductive nanostructured polymer electrodeposited on titanium as a controllable, local drug delivery platform. J. Biomed. Mater. Res. A 99A(4), 586-597 (2011).
111. Sirivisoot S, Yao C, Xiao X, Sheldon BW, Webster TJ. Greater osteoblast functions on multiwalled carbon nanotubes grown from anodized nanotubular titanium for orthopedic applications. Nanotechnology 18(36), 365102 (2007).
112. Sirivisoot S, Webster TJ. Multiwalled carbon nanotubes enhance electrochemical properties of titanium to determine in situ bone formation. Nanotechnology 19(29), 295101 (2008).
113. Gulati K, Aw MS, Losic D. Nano-engineered Ti wires for local delivery of chemotherapeutics in brain. Int. J. Nanomed. 7, 2069-2076 (2012).
114. Birdsall PD, Milne DD. Toxic shock syndrome due to percutaneous Kirschner wires. Injury 30(7), 509-510 (1999).
115. Aw MS, Simovic S, Addai-Mensah J, Losic D. Polymeric micelles in porous and nanotubular implants as a new system for extended delivery of poorly soluble drugs. J. Mater. Chem. 21, 7082-7089 (2011).